Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Celgene
>
52-week low; not a good sign
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6119773"]Don't forget that external factors can influence the stock price. Amgen presented (early!) data that week for AMG 420, an ADC targeting BCMA, that resulted in prolonged remissions in MM patients. This represents a possible threat to bb2121, although it is too early to tell where the comparative advantages lie.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6119773"]Don't forget that external factors can influence the stock price. Amgen presented (early!) data that week for AMG 420, an ADC targeting BCMA, that resulted in prolonged remissions in MM patients. This represents a possible threat to bb2121, although it is too early to tell where the comparative advantages lie.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Celgene
>
52-week low; not a good sign
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Celgene
>
52-week low; not a good sign
>